Skip to main content
. 2015 Apr 2;3(2):E149–E157. doi: 10.9778/cmajo.20140073

Table 3: Self-reported indications for flexible sigmoidoscopy or colonoscopy within preceding 10 years.

Jurisdiction; % of respondents who had test
Variable NL PEI NS NB QC ON MB SK AB BC Territories* Canada
Age 5074 yr












Family history
30.9
19.6
17.8
23.3
18.5
15.4
13.1
18.5
18.5
20.0
24.9
17.5
Routine screening
23.8
23.6
36.2
33.5
35.0
55.6
36.1
36.7
43.5
36.3
41.6
45.0
Age
2.2
9.8
4.9
8.8
6.3
15.6
8.6
7.9
8.6
5.8
9.5
10.7
Follow-up of problem
45.9
56.4
46.9
43.1
35.6
28.5
38.3
37.7
30.7
38.7
28.9
33.1
Follow-up of CRC treatment
3.3
0.1
3.1
2.9
2.9
1.3
1.6
3.3
1.6
1.8
2.6
1.9
Age 4049 yr












Family history
48.3
13.4
18.4
44.0
17.0
28.4
32.3
32.8
23.9
28.6
30.6
25.8
Routine screening
17.1
0.0
14.5
11.3
14.0
27.5
14.2
4.5
10.2
12.6
19.5
18.4
Age
0.0
0.0
0.0
1.2
5.2
3.0
3.7
0.9
0.7
0.6
1..2
2.8
Follow-up of problem
35.6
86.6
72.5
47.3
56.6
48.2
50.9
62.8
47.4
64.1
50.0
52.6
Follow-up of CRC treatment
1.2
0.0
0.0
0.4
0.1
0
0
0
0
0.5
0.8
0.2
Age ≥ 74 yr












Family history
11.1
12.5
12.1
15.1
9.5
7.7
10.4
16.2
8.6
10.4
12.1
9.3
Routine screening
21.2
30.7
30.8
34.3
45.3
57.7
38.9
33.5
50.0
43.8
53.4
49.2
Age
0.0
2.1
1.6
3.7
5.5
11.8
1.0
1.8
11.8
3.4
0.0
7.9
Follow-up of problem
65.8
56.2
49.2
50.8
34.8
33.5
44.9
51.4
29.7
38.7
28.9
36.6
Follow-up of CRC treatment 4.9 0.0 8.3 4.0 5.7 3.7 3.1 3.7 2.7 3.4 5.6 4.2

Note: AB = Alberta, BC = British Columbia, CRC = colorectal cancer, MB = Manitoba, NB = New Brunswick, NL = Newfoundland and Labrador, NS = Nova Scotia, ON = Ontario, PEI = Prince Edward Island, QC = Quebec, SK = Saskatchewan.
*Northwest Territories, Yukon and Nunavut.